Factual and Procedural Background
An interlocutory injunction was granted on 28th November 2002 by Judge Jacob J, preventing the defendants from selling a drug pending trial. The claimants, SmithKline Beecham Plc and GlaxoSmithKline (UK) Limited (referred to collectively as SB), are the proprietor and exclusive licensee of UK Patent No 2297550, which concerns paroxetine hydrochloride anhydrate, a pharmaceutical product. The defendants, Apotex Europe Limited, Neolab Limited, and Waymade Healthcare Plc (referred to collectively as Apotex), are alleged to infringe claim 11 of the patent relating to a process for preparing paroxetine hydrochloride anhydrate substantially free of bound organic solvents. The patent had been partially invalidated in previous proceedings, but claim 11 was upheld, and both parties had appealed that decision. SB sought to amend the patent in light of those proceedings. Apotex denied infringement and challenged the validity of claim 11. The interlocutory injunction was granted to maintain the status quo pending trial, where substantial issues of infringement and validity remain.
Legal Issues Presented
- Whether an interlocutory injunction should be granted to restrain the defendants from selling the allegedly infringing product pending trial.
- Whether damages for patent infringement would be recoverable and if so, whether damages would be an adequate remedy.
- Whether the patent specification was framed with reasonable skill and knowledge, affecting the recoverability of damages.
- The scope and remoteness of damages recoverable for patent infringement, specifically whether damages for loss of sales of a related but different form of the drug (hemihydrate) are too remote.
- The appropriate exercise of judicial discretion in granting or refusing interlocutory injunctions in patent cases.
Arguments of the Parties
Appellant's Arguments (Apotex)
- No interlocutory injunction should have been granted because any infringement would cause only quantifiable loss recoverable as reasonable royalties, not unquantifiable damage.
- The patent was held partially invalid except for claim 11, and SB had not demonstrated that the specification was framed with reasonable skill and knowledge, thus damages would not be recoverable.
- Damages claimed for loss to SB's hemihydrate sales were too remote from the patent covering the anhydrate form.
- It would be easier to assess damages after trial based on actual market events rather than speculative damages before trial.
- Apotex contended they did not use the patented process and therefore did not infringe claim 11.
Appellee's Arguments (SB)
- Patentees are entitled to recover damages for loss caused by infringement, which may exceed reasonable royalties depending on causation and remoteness.
- Interlocutory injunctions protect rights where damages may not be adequate, and the court's jurisdiction to grant such injunctions is not limited by the recoverability of damages.
- The specification was framed with reasonable skill and knowledge despite criticisms and proposed amendments.
- The anhydrate and hemihydrate forms of the drug are practically interchangeable, making damages for loss of hemihydrate sales not too remote.
- The judge properly exercised discretion to grant the interlocutory injunction due to the risk of substantial and unquantifiable damage to SB if Apotex entered the market.
- SB relied on precedent and legal principles establishing that the balance of convenience favored maintaining the injunction pending trial.
Table of Precedents Cited
| Precedent |
Rule or Principle Cited For |
Application by the Court |
| General Tire & Rubber Co. Ltd v. Firestone Tyre & Rubber Co. Ltd [1976] RPC 197 |
Damages for patent infringement may be based on reasonable royalties but can extend beyond, depending on causation and remoteness. |
The court rejected the submission that damages are limited to reasonable royalties, emphasizing factual assessment of loss. |
| Gerber Garments Technology Inc. v Lectra Systems [1997] RPC 443 |
Damages governed by general tort principles: foreseeability, causation, and remoteness; no special limitation under Patents Act. |
The court applied these principles to reject a narrow view of damages and supported the patentee's entitlement to recover loss caused by infringement. |
| American Cyanamid Co v Ethicon Ltd [1975] AC 396 |
Guidelines for granting interlocutory injunctions balancing adequacy of damages and balance of convenience. |
The court applied the balance of convenience test to assess whether damages would be adequate and whether to maintain the injunction. |
| Polaroid Corporation v Eastman Kodak Company [1977] RPC 379 |
Limits on damages and injunctions related to "parasitic damages" and remoteness in patent infringement. |
The court considered but distinguished the facts, concluding the principle did not bar recovery of damages for loss of related products. |
| Peaudouce SA v Kimberly-Clark Ltd [1996] FSR 680 |
Injunctions generally protect loss that would sound in damages, not loss that would not. |
The court noted the passage but held that interlocutory injunctions protect rights where damages would not be adequate, adopting a broader approach. |
| Garden Cottage Foods Ltd v Milk Marketing Board [1984] 1 AC 130 |
Appellate review of discretionary injunctions requires deference unless error of law or fact is demonstrated. |
The court deferred to the judge’s discretion in granting the interlocutory injunction absent error. |
Court's Reasoning and Analysis
The court began by affirming the principle that patentees are entitled to recover damages for loss caused by infringement, which may extend beyond reasonable royalties depending on causation and remoteness, as established in General Tire and Gerber Garments. It rejected the argument that damages are necessarily limited to reasonable royalties. The court emphasized that the jurisdiction to grant interlocutory injunctions is not constrained by the recoverability or quantum of damages; rather, the court must weigh the balance of convenience as per American Cyanamid guidelines.
The court analyzed the patent's validity, particularly whether the specification was framed with reasonable skill and knowledge. Despite criticisms and proposed amendments, the court found it was properly arguable that the specification met this threshold. The court declined to resolve factual disputes at this interlocutory stage, noting the evidential burden and the timing of submissions.
Regarding remoteness, the court found it arguable that damage to SB's hemihydrate sales caused by Apotex's anhydrate product was not too remote given their practical interchangeability. The court distinguished the Polaroid case, cautioning against overbroad application of its facts and principles.
In assessing the balance of convenience, the court accepted the trial judge’s findings that damages would not be an adequate remedy for either party due to the unquantifiable and substantial losses likely to be suffered. The court noted the risk of a price collapse and the difficulty of restoring prices if Apotex entered the market. It also recognized that Apotex had delayed addressing infringement and validity issues and had knowingly assumed the risk of injunction.
The court concluded that maintaining the interlocutory injunction pending trial was appropriate to preserve the status quo and prevent potential injustice. The appellate court deferred to the trial judge’s discretion, finding no error in principle or fact that would justify overturning the injunction.
Holding and Implications
The court DISMISSED THE APPEAL, upholding the interlocutory injunction preventing the defendants from selling the allegedly infringing product pending trial.
The direct effect is that the defendants remain restrained from marketing their product until the trial resolves the substantive issues of infringement and validity. The decision confirms the principle that interlocutory injunctions may be granted to protect patent rights even where damages might be recoverable but not adequate, and that the court will carefully weigh the balance of convenience and adequacy of damages in exercising its discretion. No new legal precedent was established; rather, the court applied established principles to the facts before it.